Regeneron donates ebola treatment for use in countries most at risk of outbreaks

Inmazeb ® (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the u.s. food and drug administration (fda) for orthoebolavirus zairense , also known as zaire ebolavirus

REGN Ratings Summary

REGN Quant Ranking